Anavex Life Sciences AVXL
NASDAQ AVXL
$2.02 -0.34 (-14.41%)
At close: Sep 30, 2026 · 4:00 PM EDT

Anavex Life Sciences (AVXL) Total Liabilities (2011 - 2026)

Updated

Anavex Life Sciences (AVXL) recorded Total Liabilities of $7.69 million in fiscal Q3 2026 (quarter ended Jun 30, 2026), down 33.0% from $11.47 million a year earlier but up 9.0% from the prior quarter.

Analysis

Anavex Life Sciences (AVXL) Total Liabilities (2011 - 2026) Analysis & Trends

At the end of FY2025 (ended Sep 30, 2025), Anavex Life Sciences reported Total Liabilities of $8.95 million, down 41.5% from FY2024.

  • Annual Total Liabilities has a five-year compound annual growth rate of 4.1% (FY2020 to FY2025).
  • Across earlier fiscal years, Total Liabilities came in at $15.3 million in FY2024 (+22.1%), $12.53 million in FY2023 (+22.7%), $10.21 million in FY2022 (-5.4%) and $10.8 million in FY2021 (+47.8%).
  • Quarterly Total Liabilities has ranged from $6.37 million in fiscal Q1 2026 to $17.38 million in fiscal Q2 2025 over the past five years.
  • On a year-over-year basis, Total Liabilities has declined for five consecutive quarters, with an average decline of 9.8% over the last eight quarters.
  • Peak year-over-year performance for Total Liabilities in the last five years was growth of 81.8% in fiscal Q2 2025, against a decline of 59.4% in fiscal Q2 2026 at the low end.
  • Per Business Quant, the preceding three fiscal quarters came in at $7.06 million (Q2 2026), $6.37 million (Q1 2026) and $8.95 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 116.09 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 141.05 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 87.82 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 80.09 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 65.46 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 83.95 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 37.53 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 115.64 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 7.18 Bn
10 Anavex Life Sciences 187.25 Mn -292.83 Mn - 7.69 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.69 Mn
Mar 31, 2026 7.06 Mn
Dec 31, 2025 6.37 Mn
Sep 30, 2025 8.95 Mn
Jun 30, 2025 11.47 Mn
Mar 31, 2025 17.38 Mn
Dec 31, 2024 13.13 Mn
Sep 30, 2024 15.30 Mn
Jun 30, 2024 11.75 Mn
Mar 31, 2024 9.56 Mn
Dec 31, 2023 12.50 Mn
Sep 30, 2023 12.53 Mn
Jun 30, 2023 11.05 Mn
Mar 31, 2023 14.02 Mn
Dec 31, 2022 13.25 Mn
Sep 30, 2022 10.21 Mn
Jun 30, 2022 9.48 Mn
Mar 31, 2022 8.07 Mn
Dec 31, 2021 10.53 Mn
Sep 30, 2021 10.80 Mn
API Access

Anavex Life Sciences Total Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-liabilities&ticker=AVXL&period=max&api_key=YOUR_API_KEY